Your browser doesn't support javascript.
loading
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
Smith, Vicky; Mukherjee, Debayan; Tsakiroglou, Anna Maria; Baker, Alexander; Mistry, Hitesh; Choudhury, Ananya; Hoskin, Peter; Illidge, Timothy; West, Catharine M L.
Afiliación
  • Smith V; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Mukherjee D; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Tsakiroglou AM; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Baker A; Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.
  • Mistry H; Division of Pharmacy and Optometry, University of Manchester, Manchester M13 9PL, UK.
  • Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Hoskin P; Manchester Academic Health Science Centre, Manchester M13 9NQ, UK.
  • Illidge T; Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK.
  • West CML; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Cancers (Basel) ; 15(1)2022 Dec 21.
Article en En | MEDLINE | ID: mdl-36612036
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido